These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20086117)

  • 1. The association of metabolic syndrome and its components with serum prostate-specific antigen levels in a Korean-screened population.
    Jeong IG; Hwang SS; Kim HK; Ahn H; Kim CS
    Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):371-80. PubMed ID: 20086117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Actual lowering effect of metabolic syndrome on serum prostate-specific antigen levels is partly concealed by enlarged prostate: results from a large-scale population-based study.
    Zhao S; Xia M; Tang J; Yan Y
    BJU Int; 2017 Oct; 120(4):482-489. PubMed ID: 27489082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of metabolic syndrome and its components with serum prostate-specific antigen levels.
    Gao X; Bao T; Yang H; Lei Y; Jiang X; Huang Y; Huang W; Tang H
    Eur J Cancer Prev; 2020 Jan; 29(1):36-41. PubMed ID: 30913093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome-like components and prostate cancer risk: results from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) study.
    Sourbeer KN; Howard LE; Andriole GL; Moreira DM; Castro-Santamaria R; Freedland SJ; Vidal AC
    BJU Int; 2015 May; 115(5):736-43. PubMed ID: 24931061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, haemodynamic, anthropometric, metabolic and insulin profile of men with high-stage and high-grade clinical prostate cancer.
    Hammarsten J; Högstedt B
    Blood Press; 2004; 13(1):47-55. PubMed ID: 15083641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J; Högstedt B
    Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancer.
    Hammarsten J; Högstedt B
    Eur J Cancer; 2005 Dec; 41(18):2887-95. PubMed ID: 16243513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic Syndrome Components are Associated with Increased Prostate Cancer Risk.
    Zhang JQ; Geng H; Ma M; Nan XY; Sheng BW
    Med Sci Monit; 2015 Aug; 21():2387-96. PubMed ID: 26275075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of metabolic syndrome-related factors on the development of benign prostatic hyperplasia and lower urinary tract symptoms in Asian population.
    Park JS; Koo KC; Kim HK; Chung BH; Lee KS
    Medicine (Baltimore); 2019 Oct; 98(42):e17635. PubMed ID: 31626149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum prostate-specific antigen hemodilution among obese men undergoing screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Grubb RL; Black A; Izmirlian G; Hickey TP; Pinsky PF; Mabie JE; Riley TL; Ragard LR; Prorok PC; Berg CD; Crawford ED; Church TR; Andriole GL;
    Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):748-51. PubMed ID: 19258472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between prostate-specific antigen and obesity in prostate cancer screening: analysis of a large cohort in Japan.
    Kubota Y; Seike K; Maeda S; Shinohara Y; Iwata M; Sugimoto N
    Int J Urol; 2011 Jan; 18(1):72-5. PubMed ID: 21198939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlations of Metabolic Components with Prostate Volume in Middle-Aged Men Receiving Health Check-Up.
    Yang TK; Woo P; Yang HJ; Chang HC; Hsieh JT; Huang KH
    PLoS One; 2016; 11(1):e0145050. PubMed ID: 26731481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer.
    Bañez LL; Hamilton RJ; Partin AW; Vollmer RT; Sun L; Rodriguez C; Wang Y; Terris MK; Aronson WJ; Presti JC; Kane CJ; Amling CL; Moul JW; Freedland SJ
    JAMA; 2007 Nov; 298(19):2275-80. PubMed ID: 18029831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome is associated with high grade Gleason score when prostate cancer is diagnosed on biopsy.
    De Nunzio C; Freedland SJ; Miano R; Trucchi A; Cantiani A; Carluccini A; Tubaro A
    Prostate; 2011 Oct; 71(14):1492-8. PubMed ID: 21360562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity inversely correlates with prostate-specific antigen levels in a population with normal screening results of prostate cancer in northwestern China.
    Zhang J; Ma M; Nan X; Sheng B
    Braz J Med Biol Res; 2016 Jul; 49(8):. PubMed ID: 27409334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of body mass index and waist circumference on prostate specific antigen and prostate volume in a generally healthy Korean population.
    Park JH; Cho BL; Kwon HT; Lee CM; Han HJ
    J Urol; 2009 Jul; 182(1):106-10; discussion 110-1. PubMed ID: 19450837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol reduces the levels of circulating androgen precursors but has no effect on, testosterone, dihydrotestosterone, PSA levels or prostate volume. A 4-month randomised trial in middle-aged men.
    Kjaer TN; Ornstrup MJ; Poulsen MM; Jørgensen JO; Hougaard DM; Cohen AS; Neghabat S; Richelsen B; Pedersen SB
    Prostate; 2015 Sep; 75(12):1255-63. PubMed ID: 25939591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body mass index in relation to prostate-specific antigen-related parameters.
    Lin D; Liu T; Chen L; Chen Z
    BMC Urol; 2021 Sep; 21(1):130. PubMed ID: 34530776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening Prostate-specific Antigen Concentration and Prostate Cancer Mortality: The Korean Heart Study.
    Mok Y; Kimm H; Shin SY; Jee SH; Platz EA
    Urology; 2015 May; 85(5):1111-1116. PubMed ID: 25917733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity is negatively associated with prostate-specific antigen in U.S. men, 2001-2004.
    Werny DM; Thompson T; Saraiya M; Freedman D; Kottiri BJ; German RR; Wener M
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):70-6. PubMed ID: 17179487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.